| Characteristic | Biotech with low AI adoption | Biotech with higher AI adoption |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Source
Release date
January 2026
More information
Region
North America, Europe
Survey time period
November 2025
Number of respondents
104 biotech and pharma organizations
Supplementary notes
Data integration levels:
- Highly siloed - disconnected data
- Early stage - some data accessible. But largely fragmented and manualÂ
- Developing - key datasets connected, but inconsistent standards and gaps remain
- Advanced - most data standardized and accessible, with reliable pipelines.Â
- Fully integrated - data is curated, standardized, and accessible across R&D functions.
Citation formats
